Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer

BACKGROUND: PCDH8 is a newly-discovered suppressor gene that is frequently inactivated by aberrant methylation in several human cancers, including prostate cancer. The identification of PCDH8 methylation can be used as a potential predictive biomarker. Prostate cancer patients with high Gleason scor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ying-Li, Li, Yan-Li, Ma, Jian-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652140/
https://www.ncbi.nlm.nih.gov/pubmed/29026066
http://dx.doi.org/10.12659/MSM.904366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652140/
https://www.ncbi.nlm.nih.gov/pubmed/29026066
http://dx.doi.org/10.12659/MSM.904366

Ejemplares similares